Notably, EEC G3 harbors the highest frequency of MMR mutations among endometrial cancers and could be prioritized for MMR mutation screening, as they exhibit a higher prevalence of these alterations than EEC G1 and G2. Here, MRC1 is linked to endometrial cancer.